Company / Book Value per Share
KalVista Pharmaceuticals, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.243
FY2025
5-year range
$2.243 / $14.412
FY2021-FY2025
Trend
-46.1%
vs FY2024
Sector context
#144 of 209
Health Care
What the data says
At $2.243, KalVista Pharmaceuticals, Inc.'s book value per share ranks #144 of 209 in the Health Care sector. Book Value per Share has declined for 4 consecutive years, from $14.412 in FY2021 to $2.243 in FY2025.
Based on SEC 10-K filings.
$2.243 in FY2025 with a 5-year CAGR of -14.3%.
Declined from $4.377 to $2.243 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -33.4%
- 5-Year CAGR
- -14.3%
- 10-Year CAGR
- -
Sector benchmark
#144 of 209 in Health CareTop 69% of 209This company $2.243 Sector average $215.686
▼
-99.0% below sector average
Key checks
Key Insights
- KalVista Pharmaceuticals, Inc.'s book value per share has declined for 4 consecutive years.
- 5-year CAGR of -14.3%, indicating a declining trend.
- In FY2025, book value per share decreased 46.1% year-over-year.
- Ranks #144 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.243 | -46.1% |
| FY2024 | $4.161 | -5.0% |
| FY2023 | $4.377 | -42.2% |
| FY2022 | $7.579 | -47.4% |
| FY2021 | $14.412 | +197.3% |
| FY2020 | $4.847 | +241.1% |
| FY2019 | -$3.436 | -41.7% |
| FY2018 | -$2.425 | -179.9% |
| FY2017 | $3.035 | +138.0% |
| FY2016 | -$7.987 | +91.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026